£41.00

It has never been this cheap. We have no record of a lower price.

£41 today · cheaper than every other day in the last 3 months

VDM Verlag Sequential therapy in metastatic breast cancer patients: Survival analysis with time dependent covariates

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 56 days · 56 data points (no recent data)

Historical
Generating forecast…
£41.00 £38.95 £39.77 £40.59 £41.41 £42.23 £43.05 23 July 2026 05 August 2026 19 August 2026 02 September 2026 16 September 2026
View at Amazon ↗

Price data last checked 35 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 56 days • 1 price levels

Days at Price
56 days 0 14 28 42 56 £41 Days at Price

Price Analysis

Most common price: £41 (56 days, 100.0%)

Price range: £41 - £41

Price levels: 1 different prices over 56 days

Description

Metastatic breast cancer is a disease with a high mortality rate. Taxanes, a specific class of chemotherapeutic agents including Taxol® and Taxotere® have been demonstrated to be effective in tumor control and symptom relief in metastatic breast cancer patients. However, it was unclear whether there is a benefit in survival compared to non-taxane compounds. This study evaluated the effect of taxanes within the clinical setting during patients' individual courses of sequential treatments. Metastatic breast cancer patients were recruited from one practice of the University of Pittsburgh Cancer Institute Breast Cancer Program within the time frame of January 1999 to July 2005. Taxanes were beneficial for survival in women with metastatic breast cancer. However, the effect strongly depended on the estrogen receptor type. Patients who had metastatic breast cancer with negative estrogen receptors benefited enormously from taxane therapy. These results will assist clinicians in choosing the best therapeutic regimes and may facilitate the development of guidelines for the management of metastatic breast cancer.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
18 June 2010
Listed Since
25 June 2010

Barcode

No barcode data available

Similar Products You Might Like

Adjuvant Therapy of Breast Cancer V: 140 (Recent Results in Cancer Research, 140)
79% match

Adjuvant Therapy of Breast Cancer V: 140 (Recent Results in Cancer Research, 140)

Springer

£76.42 18 Aug 2026
Adjuvant Therapy of Breast Cancer: 60 (Cancer Treatment and Research, 60)
79% match

Adjuvant Therapy of Breast Cancer: 60 (Cancer Treatment and Research, 60)

Springer

£148.28 05 Aug 2026
Breast Cancer Metastasis and Drug Resistance: Progress and Prospects
79% match

Breast Cancer Metastasis and Drug Resistance: Progress and Prospects

Springer

£125.82 15 Sep 2026
Resistance to Targeted Therapies in Breast Cancer: 16 (Resistance to Targeted Anti-Cancer Therapeutics, 16)
79% match

Resistance to Targeted Therapies in Breast Cancer: 16 (Resistance to Targeted Anti-Cancer Therapeutics, 16)

Springer

£80.65 06 Aug 2026
Breast Cancer Chemosensitivity: 608 (Advances in Experimental Medicine and Biology, 608)
79% match

Breast Cancer Chemosensitivity: 608 (Advances in Experimental Medicine and Biology, 608)

Springer

£92.50 14 Sep 2026
Signaling Pathways in Breast Cancer: Molecular Mechanisms, Therapeutic Strategies, and Multidrug Resistance
78% match

Signaling Pathways in Breast Cancer: Molecular Mechanisms, Therapeutic Strategies, and Multidrug Resistance

Elsevier

£145.99 04 Aug 2026
Prognostic variables in node-negative and node-positive breast cancer
78% match

Prognostic variables in node-negative and node-positive breast cancer

Springer

£153.04 05 Aug 2026
A Practical Guide to Breast Cancer Treatment
78% match

A Practical Guide to Breast Cancer Treatment

Springer

£115.72 04 Aug 2026
New Developments in Visual Attention Research (Psychology Research Progress)
78% match

New Developments in Visual Attention Research (Psychology Research Progress)

£119.99 15 Sep 2026
Therapeutic Management of Metastatic Breast Cancer: 1 (Consensus Development in Cancer Therapy, 1)
78% match

Therapeutic Management of Metastatic Breast Cancer: 1 (Consensus Development in Cancer Therapy, 1)

De Gruyter

£105.50 15 Sep 2026
Treatment of Malignant Breast Tumors: Indications and Results A Study Based on 1174 Cases Treated at the Institut Gustave-Roussy between 1954 and 1962: 31 (Recent Results in Cancer Research, 31)
78% match

Treatment of Malignant Breast Tumors: Indications and Results A Study Based on 1174 Cases Treated at the Institut Gustave-Roussy between 1954 and 1962: 31 (Recent Results in Cancer Research, 31)

Springer

£73.96 15 Sep 2026
Endocrine Therapy of Breast Cancer VI (ESO Monographs)
78% match

Endocrine Therapy of Breast Cancer VI (ESO Monographs)

Springer

£76.42 07 Aug 2026
Triple-Negative Breast Cancer: A Clinician’s Guide
78% match

Triple-Negative Breast Cancer: A Clinician’s Guide

Springer

£80.67 21 Oct 2026
Sport und Bewegung bei Brustkrebs: Effekte, Prävalenz und Determinanten körperlicher Aktivität nach einer Brustkrebsdiagnose
77% match

Sport und Bewegung bei Brustkrebs: Effekte, Prävalenz und Determinanten körperlicher Aktivität nach einer Brustkrebsdiagnose

VDM Verlag

£43.00 22 Aug 2026
Breast Cancer Management for Surgeons: A European Multidisciplinary Textbook
77% match

Breast Cancer Management for Surgeons: A European Multidisciplinary Textbook

Springer

£156.70 05 Aug 2026
Management of Breast Diseases
77% match

Management of Breast Diseases

Springer

£104.99 14 Sep 2026
Breast Cancer: Evolving Challenges and Next Frontiers
77% match

Breast Cancer: Evolving Challenges and Next Frontiers

IntechOpen

£119.00 29 Aug 2026
Breast Cancer (MD Anderson Solid Tumor Oncology Series)
77% match

Breast Cancer (MD Anderson Solid Tumor Oncology Series)

Springer

£78.01 13 Aug 2026
Breast Cancer: Nuclear Medicine in Diagnosis and Therapeutic Options
77% match

Breast Cancer: Nuclear Medicine in Diagnosis and Therapeutic Options

Springer

£60.45 08 Aug 2026
Breast Cancer, An Issue of Hematology/Oncology Clinics of North America (Volume 27-4) (The Clinics: Internal Medicine, Volume 27-4)
77% match

Breast Cancer, An Issue of Hematology/Oncology Clinics of North America (Volume 27-4) (The Clinics: Internal Medicine, Volume 27-4)

Elsevier

£55.49 04 Aug 2026
Endocrine Therapies in Breast and Prostate Cancer: 39 (Cancer Treatment and Research, 39)
77% match

Endocrine Therapies in Breast and Prostate Cancer: 39 (Cancer Treatment and Research, 39)

Springer

£122.14 18 Aug 2026
Adjuvant Chemotherapy of Breast Cancer: Papers Presented at the 2nd International Conference on Adjuvant Chemotherapy of Breast Cancer, Kantonsspital ... 96 (Recent Results in Cancer Research, 96)
77% match

Adjuvant Chemotherapy of Breast Cancer: Papers Presented at the 2nd International Conference on Adjuvant Chemotherapy of Breast Cancer, Kantonsspital ... 96 (Recent Results in Cancer Research, 96)

Springer

£76.23 31 Aug 2026
Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)
77% match

Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)

Springer

£103.27 08 Aug 2026
Short Course Breast Radiotherapy: A Comprehensive Review of Hypofractionation, Partial Breast, and Intra-Operative Irradiation
77% match

Short Course Breast Radiotherapy: A Comprehensive Review of Hypofractionation, Partial Breast, and Intra-Operative Irradiation

Springer

£115.43 14 Sep 2026